SCHEMBL20235791

SCHEMBL20235791

C/C=C/C(=O)NCCCC[C@H](NC(=O)CNC(=O)CNC(C)C)C(=O)CC

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ APEX1 P27695 1/20 0.32
▸ TGM2 P21980 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16231526 0.88 APEX1 (0.32) APEX1TGM2
SCHEMBL20235717 0.85 FOLH1 (0.40) —
SCHEMBL16231530 0.84 APEX1 (0.34) APEX1TGM2
SCHEMBL20235782 0.82 CAPN1 (0.33) —
SCHEMBL20235773 0.81 PRSS1 (0.30) —
SCHEMBL20235581 0.81 EPHX1 (0.42) —
SCHEMBL20235803 0.81 FOLH1 (0.38) —
SCHEMBL20235790 0.77 APEX1 (0.31) APEX1
SCHEMBL14932603 0.77 APEX1 (0.34) APEX1TGM2
SCHEMBL20235700 0.77 FOLH1 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10626438-B2 Fluorescent substrates for determining lysine modifying enzyme activity THE BROAD INSTITUTE, INC. (US) 2020-04-21 — — US disclosed
US-20180155760-A1 FLUORESCENT SUBSTRATES FOR DETERMINING LYSINE MODIFYING ENZYME ACTIVITY BROAD INST INC (US) 2018-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180155760-A1 FLUORESCENT SUBSTRATES FOR DETERMINING LYSINE MODIFYING ENZYME ACTIVITY KDM1A, MAN2B1, KDM3A APEX1 267/4885TGM2 1265/4885
US-10626438-B2 Fluorescent substrates for determining lysine modifying enzyme activity KDM1A, MAN2B1, KDM3A APEX1 267/4885TGM2 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback